Rectal Ozone as Neuroprotector Post CNS Insult in Children
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-18
SponsorAl-Azhar University
This study aims to evaluate the efficacy of rectal ozone therapy as a neuroprotective modality in Pediatric acquired brain injury.
Age from 1 month to 18 years.
Both sexes.
Children admitted to the pediatric intensive care unit (PICU) with acquired neurological insult.
Children with neurological sequelae
Patients with no degree of disability or sequelae.
Patients not fit for Rectal ozone therapy.
Patients with active epilepsy and recurrent seizures.
Children with a positive family history of degenerative brain insults.